BACKGROUND: By using array comparative genomic hybridization (CGH), the increased copy number of CYP24 (which encodes vitamin D 24-hydroxylase) at 20q13.2 was previously reported, leading to the identification of CYP24 as a candidate oncogene in breast cancer. CYP24 leads to abrogate growth control mediated by vitamin D. MATERIALS AND METHODS: We examined CYP24 expression as well as VDR (vitamin D receptor) gene expression in 42 esophageal cancer cases using semi-quantitative RT-PCR assay. We induced CYP24 in seven esophageal cancer cell lines using 25-hydroxyvitamin D3 [25(OH)D3] and compared cell growth rate, measured using the 3-(4, 5-dimethylthiazol-2-y)-2, 5-diphenyltetrazolium bromide (MTT) assay system. RESULTS: The overall survival rate was significantly higher in 25 cases of lower CYP24 expression than 17 cases of higher CYP24 expression (P <0.05); on the other hand, 23 cases of low VDR expression had a poorer prognosis than 19 cases of high VDR expression. Moreover, we disclosed that the inverse correlation between CYP24 and VDR expression is significant in esophageal cancer cases (P <0.05). Furthermore, the cell growth evaluated by MTT assay was greatly increased in CYP24-induced and VDR-diminished cells than non-responding cells by 25(OH)D3 activity (P <0.01). CONCLUSIONS: Overexpression of the candidate oncogene CYP24 is inversely correlated to vitamin D receptor expression, and may play an important role in determination of the malignant potential of esophageal cancer.
BACKGROUND: By using array comparative genomic hybridization (CGH), the increased copy number of CYP24 (which encodes vitamin D 24-hydroxylase) at 20q13.2 was previously reported, leading to the identification of CYP24 as a candidate oncogene in breast cancer. CYP24 leads to abrogate growth control mediated by vitamin D. MATERIALS AND METHODS: We examined CYP24 expression as well as VDR (vitamin D receptor) gene expression in 42 esophageal cancer cases using semi-quantitative RT-PCR assay. We induced CYP24 in seven esophageal cancer cell lines using 25-hydroxyvitamin D3 [25(OH)D3] and compared cell growth rate, measured using the 3-(4, 5-dimethylthiazol-2-y)-2, 5-diphenyltetrazolium bromide (MTT) assay system. RESULTS: The overall survival rate was significantly higher in 25 cases of lower CYP24 expression than 17 cases of higher CYP24 expression (P <0.05); on the other hand, 23 cases of low VDR expression had a poorer prognosis than 19 cases of high VDR expression. Moreover, we disclosed that the inverse correlation between CYP24 and VDR expression is significant in esophageal cancer cases (P <0.05). Furthermore, the cell growth evaluated by MTT assay was greatly increased in CYP24-induced and VDR-diminished cells than non-responding cells by 25(OH)D3 activity (P <0.01). CONCLUSIONS: Overexpression of the candidate oncogene CYP24 is inversely correlated to vitamin D receptor expression, and may play an important role in determination of the malignant potential of esophageal cancer.
Authors: Andrew J Annalora; Ekaterina Bobrovnikov-Marjon; Rita Serda; Andrzej Pastuszyn; Sandra E Graham; Craig B Marcus; John L Omdahl Journal: Arch Biochem Biophys Date: 2006-12-03 Impact factor: 4.013
Authors: Kristin K Deeb; Wei Luo; Adam R Karpf; Angela R Omilian; Wiam Bshara; Lili Tian; Michael A Tangrea; Carl D Morrison; Candace S Johnson; Donald L Trump Journal: Epigenetics Date: 2011-08-01 Impact factor: 4.528
Authors: Josephia R Muindi; Wei-Dong Yu; Yingyu Ma; Kristie L Engler; Rui-Xian Kong; Donald L Trump; Candace S Johnson Journal: Endocrinology Date: 2010-06-30 Impact factor: 4.736
Authors: Henrik C Horváth; Péter Lakatos; János P Kósa; Krisztián Bácsi; Katalin Borka; Giovanna Bises; Thomas Nittke; Pamela A Hershberger; Gábor Speer; Enikö Kállay Journal: J Histochem Cytochem Date: 2009-11-09 Impact factor: 2.479
Authors: Wei Luo; Wei-Dong Yu; Yingyu Ma; Mikhail Chernov; Donald L Trump; Candace S Johnson Journal: Cancer Res Date: 2013-01-28 Impact factor: 12.701